Clinical trial
The Impact of Hyperemic State on the Performance of Angiography Derived Indices in Assessing Coronary Microvascular Disease
NCT07613996 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Hyperemic State on the Performance of Angiography Derived Indices in Assessing Coronary Microvascular Disease
- Lead sponsor
- Shanghai Zhongshan Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 4, 2026
- Completion date
- December 31, 2026
- Enrollment
- 192 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease, microvascular coronary artery disease